Jade Biosciences (JBIO) Enterprise Value (2020 - 2026)
Jade Biosciences (JBIO) posted Enterprise Value of -$311.3 million for Q1 2026, up 7.4% on a QoQ basis from -$336.2 million in Q4 2025, and down 308.47% year-over-year from $149.3 million in Q1 2025.
Jade Biosciences (JBIO) Enterprise Value (2020 - 2026) Analysis & Trends
Jade Biosciences' Enterprise Value history runs 7 years deep, the most recent figure standing at -$311.3 million for Q1 2026.
- Quarterly Enterprise Value fell 308.47% year-over-year to -$311.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$311.3 million (down 308.47% YoY) and the FY2025 annual result came in at -$336.2 million, down 384.48% from the prior year.
- Enterprise Value was -$311.3 million for Q1 2026 at Jade Biosciences, up from -$336.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$59.6 million in Q2 2022 and bottomed at -$336.2 million in Q4 2025.
- A 5-year average of -$153.7 million and a median of -$129.2 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value soared 56.45% — and 2025, when it plunged 384.48%.
- Jade Biosciences' Enterprise Value stood at -$129.2 million in 2022, then increased by 5.25% to -$122.4 million in 2023, then soared by 43.33% to -$69.4 million in 2024, then plunged by 384.48% to -$336.2 million in 2025, then advanced by 7.4% to -$311.3 million in 2026.
- Business Quant data shows JBIO's Enterprise Value at -$311.3 million in Q1 2026, -$336.2 million in Q4 2025, and -$198.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | -311.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -311.30 Mn |
| Dec 31, 2025 | -336.16 Mn |
| Sep 30, 2025 | -198.91 Mn |
| Jun 30, 2025 | -220.90 Mn |
| Mar 31, 2025 | -76.21 Mn |
| Dec 31, 2024 | -69.39 Mn |
| Sep 30, 2024 | -88.73 Mn |
| Jun 30, 2024 | -104.20 Mn |
| Mar 31, 2024 | -99.33 Mn |
| Dec 31, 2023 | -122.44 Mn |
| Sep 30, 2023 | -135.20 Mn |
| Jun 30, 2023 | -239.30 Mn |
| Mar 31, 2023 | -118.93 Mn |
| Dec 31, 2022 | -129.22 Mn |
| Sep 30, 2022 | -142.58 Mn |
| Jun 30, 2022 | -59.60 Mn |
| Mar 31, 2022 | -161.07 Mn |
| Dec 31, 2021 | -167.38 Mn |
| Sep 30, 2021 | -180.90 Mn |
| Jun 30, 2021 | -55.15 Mn |